Jeffrey B. McGroarty
Senior Vice President and Chief Financial Officer
Providing Financial and Strategic Leadership.
Jeff has more than 20 years of accounting and financial experience. With a successful track record in corporate accounting, Jeff oversees all of Safeguard’s financial and reporting matters and guides Safeguard’s partner companies to help optimize their own financial operations.
As Senior Vice President and Chief Financial Officer at Safeguard, Jeff is responsible for the management of Safeguard’s accounting, financial operations, SEC reporting, treasury and tax functions, as well as human resources. In addition, Jeff provides guidance to Safeguard’s partner companies on accounting operations, valuations, internal controls, accounting and tax issues. Jeff joined Safeguard in December 2005 as Vice President and Corporate Controller.
Prior to joining Safeguard, Jeff was interim controller at Cephalon, Inc. (NASDAQ:CEPH), an international biopharmaceutical company. In addition, he was Vice President, Financial Planning and Analysis at Exide Technologies (NASDAQ:XIDE), a global manufacturer and recycler of lead-acid batteries. While at Exide, Jeff played a major role in the company’s reorganization and emergence from bankruptcy. Jeff began his career at PricewaterhouseCoopers LLP, where he had management responsibility for domestic and international audits, due diligence, consulting and post M&A integration in the U.S. and U.K.
A Certified Public Accountant, Jeff earned his B.A. in accounting from Pennsylvania State University and has an M.B.A. from The Wharton School of the University of Pennsylvania.
"Safeguard’s finance team helps our partner companies build a strong financial and human resources infrastructure to ensure accountability and compliance, driving value in our partner company’s fundamentals."
March 7, 2017
This post originally appeared on CIOReview.com on March 6th, 2017. By: Peter Coffee, VP for Strategic Research, Salesforce and Scott Snyder, Chief Technology and Innovation Officer,…
February 7, 2017
Nearly 60 percent of all U.S. venture capital activity is concentrated in the Bay Area, Boston metro, and New York City’s orbit. For some entrepreneurs,…
January 26, 2017
Over the last 18 months, an alarming number of medical device companies’ challenges with data security have been exposed. In 2015, Hospira’s LifeCare PCA3 and…